BioSig raises ~$1.45M in equity at $0.41/share; warrant repricing generates additional $218K

Streamex Corp.

Sold 3,541,469 shares at $0.41 each to accredited investors for aggregate proceeds of $1,452,000.
Reduced March Warrants exercise price from $1.40 to $0.25 for a limited window; 510,000 shares issued for $127,500.
Total proceeds from offering and warrant exercises combined are $1,670,250.
Warrant pricing reduction applied only through November 10, 2022; total March Warrants exercised to date: 873,000 shares.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Streamex Corp. entered into Securities Purchase Agreement with certain accredited investors valued at $1,452,000 (effective 2022-11-18).

Action: entry
Agreement: equity purchase
Counterparty: certain accredited investors
Value: $1,452,000
Effective: 2022-11-18

Exact text from the filing

On November 18, 2022, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 3,541,469 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $0.41 per share, in exchange for aggregate consideration of $1,452,000.

View on SEC.gov

275 material agreements filed in the last 30 days. Browse all material agreements →

Streamex Corp. filing history →

Source: SEC EDGAR

accession 0001185185-22-001335

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.